Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Prime Medicine Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
PRME
Nasdaq
8731
https://primemedicine.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Prime Medicine Inc
Prime Medicine to Present Preclinical Data Demonstrating Broad Potential of Prime Editing Technology at Upcoming Scientific Meetings
- Apr 23rd, 2024 12:00 pm
2 Magnificent Growth Stocks With Room to Run
- Mar 27th, 2024 12:45 pm
Short-Squeeze Roulette: 3 Stocks That Could Leave Bears Begging
- Mar 14th, 2024 6:44 pm
Cathie Wood Just Bought These 3 Biotech Stocks. Should You Buy, Too?
- Mar 1st, 2024 7:00 pm
Prime Medicine Reports Full Year 2023 Financial Results and Provides Business Updates
- Mar 1st, 2024 1:00 pm
14 Stocks With Heavy Insider Buying In 2024
- Feb 29th, 2024 8:02 am
Prime Medicine to Participate in Upcoming Investor Conferences
- Feb 28th, 2024 1:00 pm
With 34% ownership, Prime Medicine, Inc. (NASDAQ:PRME) has piqued the interest of institutional investors
- Feb 25th, 2024 2:20 pm
Prime Medicine Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
- Feb 20th, 2024 9:01 pm
Prime Medicine Announces Pricing of Upsized Public Offering
- Feb 15th, 2024 4:50 am
Prime Medicine Announces Proposed Public Offering of Common Stock
- Feb 14th, 2024 9:05 pm
Prime Medicine to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
- Feb 1st, 2024 1:00 pm
Prime Medicine Receives Up to $15 Million from Cystic Fibrosis Foundation to Advance Hotspot and PASSIGE™ Prime Editors for Cystic Fibrosis
- Jan 25th, 2024 1:00 pm
Wall Street Analysts Predict an 111.38% Upside in Prime Medicine, Inc. (PRME): Here's What You Should Know
- Jan 9th, 2024 11:21 pm
Prime Medicine Appoints Allan Reine, M.D., as Chief Financial Officer
- Jan 5th, 2024 1:00 pm
Prime Medicine to Present at 42nd Annual J.P. Morgan Healthcare Conference
- Jan 2nd, 2024 1:00 pm
Better Growth Stock: Archer Aviation or Prime Medicine?
- Dec 19th, 2023 3:30 pm
1 Cathie Wood Stock That Could Deliver Life-Changing Returns in 10 Years
- Nov 30th, 2023 12:45 pm
Prime Medicine to Present at Upcoming Investor Conferences
- Nov 8th, 2023 1:00 pm
Prime Medicine Reports Third Quarter 2023 Financial Results and Provides Business Updates
- Nov 3rd, 2023 8:01 pm
Scroll